The WHO recommends the new preventive injection against HIV, approximately one month after the FDA approved the drug

ntn24 The World Health Organization (WHO) recommends that countries include the new treatment to prevent Human Immunodeficiency Virus (HIV), which was recently approved by the United States Food and Drug Administration (FDA).

This is lenacapavir, a long-acting injectable medication for the prevention of HIV, especially for high-risk groups and in areas where the risk remains high.

The global recommendation was made during the 13th International AIDS Society Conference currently taking place in Rwanda, where the latest WHO recommendations on prevention, diagnosis, and treatment of this disease are being discussed.